Biochem/physiol Actions
Reversible: no
Product does not compete with ATP.
Primary TargetBlocks brefeldin A-dependent mono-ADP-ribosylation in vitro
Target IC50: 180 µM and 150 µM in blocking brefeldin A-dependent mono-ADP-ribosylation in vitro and Golgi disassembly in living cells, respectively
Cell permeable: yes
General description
A cell-permeable quinone reductase inhibitor with anti-coagulant properties. Binds competitively with NADH or NADPH to inhibit NAD(P)H:quinone oxidoreductase (NQO1). Shown to inhibit IGF-I-, menadione-, and DMNQ-mediated activation of stress-activated protein kinase/c-jun NH2-terminal kinase (SAPK/JNK) and subsequent phosphorylation of c-Jun, as well as stress-induced activation (hypertonic sorbitol) of SAPK/JNK. Does not affect p38 phosphorylation or protein kinase B (AKT) activation. Also shown to induce apoptosis in MCF7 breast carcinoma cells. Inhibits glutathione-S transferase (GST) A1-1 enzyme (Kiu = 4.4 µM, Kic = 3.6 µM) in vitro and in MCF7/VPα cells (a multidrug resistant derivative of MCF7 transfected with GST A1-1). Blocks brefeldin A-dependent mono-ADP-ribosylation in vitro and Golgi disassembly in living cells (IC50 = 180 µM and 150 µM, respectively).
A cell-permeable quinone reductase inhibitor with anticoagulant properties. Potentiates apoptosis by simultaneously blocking SAPK/JNK and NF-κB pathways. Does not affect phosphorylation of p38 or activation of AKT. Blocks brefeldin A-dependent mono-ADP-ribosylation in vitro and Golgi disassembly in living cells (IC50 = 180 µM and 150 µM, respectively).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Seanor, K.L., et al. 2003. Antioxid. Redox. Signal5, 103.Krause, D., et al. 2001. J. Biol. Chem.276, 19244.Pink, J.J., et al. 2000. J. Biol. Chem.275, 5416.Cross, J.V., et al. 1999. J. Biol. Chem.274, 31150.Morrow, C.S., et al. 1998. J. Biol. Chem.273, 20114.Weigert, R., et al. 1997. J. Biol. Chem.272, 14200.
Packaging
Packaged under inert gas
500 mg in Glass bottle
Reconstitution
Unstable in solution; reconstitute just prior to use.
Warning
Toxicity: Toxic & Carcinogenic / Teratogenic (G)
This product has met the following criteria to qualify for the following awards: